GlassScriptPhysician profile
Alison A Holland
NPI 1174800429
$1,033.45
in general payments reported to CMS, 2019-2025
14 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.47 · 2022: $50.27 · 2023: $191 · 2024: $216 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $467.61 | 2024-2025 | Wegovy |
| Myriad Genetic Laboratories, INC. | $173.65 | 2023-2024 | Myrisk |
| Davol INC. | $75.78 | 2025 | Phasix Mesh |
| Abbvie INC. | $73.84 | 2021-2024 | |
| Baxter Healthcare | $47.20 | 2024-2025 | Perclot |
| Tela Bio, INC. | $39.38 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $31.47 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Takeda Pharmaceuticals U.S.A., INC. | $29.14 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.42 | 2025 | |
| Ethicon US, LLC | $19.45 | 2022 | |
| Thd America, INC. | $16.04 | 2025 | |
| Redhill Biopharma INC. | $15.55 | 2022 | |
| Pfizer INC. | $15.27 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $8.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Holland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.